Navigation Links
Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress
Date:2/25/2008

d 134,669,590 132,953,759 134,333,418 131,815,414

(a) Includes stock-based compensation expense of $3,454 ($0.03 per

share) and $3,856 ($0.03 per share) for the three months ended

December 31, 2007 and 2006, respectively. Includes stock-based

compensation expense of $13,278 ($0.10 per share) and $16,337 ($0.13

per share) for the twelve months ended December 31, 2007 and 2006,

respectively. Includes expenses of $16,852 ($0.13 per share) for the

three and twelve months ended December 31, 2007 related to the

licensing and collaboration agreement entered into with Aegera

Therapeutics.

(b) Includes stock-based compensation expense of $1,807 ($0.02 per share)

and $2,683 ($0.02 per share) for the three months ended December 31,

2007 and 2006, respectively. Includes stock-based compensation

expense of $8,413 ($0.07 per share) and $10,270 ($0.08 per share) for

the twelve months ended December 31, 2007 and 2006, respectively.

CONSOLIDATED BALANCE SHEET DATA:

As of As of

December 31, 2007 December 31, 2006

(dollars in thousands)

Cash, cash equivalents and

investments ( c ) $603,840 $763,084

Total assets ( c ) 949,105 1,149,668

Total debt, less current portion 754,099 751,526

Total stockholders' equity (deficit) (11,902) 213,923

( c ) Includes $70,931 and $61,165 in restricted investments at December

31, 2007 and December 31, 2006, respectively.


'/>"/>
SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
3. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
4. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
5. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
9. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
11. Premier Research Appoints Global Head of Human Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich Corporation ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements ... expired on December 22, 2014, thereby completing the ... for the acquisition of the Company by Merck ... clearance satisfies another condition to closing the transaction, ...
(Date:12/22/2014)... 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, ... today announced positive topline safety and tolerability ... of SYN-004, the Company,s investigational oral beta-lactamase ... difficile (C. difficile) infection, antibiotic-associated diarrhea ...
(Date:12/22/2014)... 2014  ( www.competitivehealth.com ) — Competitive Health is ... review and advocacy service, has signed an agreement to ... discount health services marketplace. 63% of Americans ... they expected to pay. As part of an ongoing ... Savings is pleased to offer medical bill review and ...
(Date:12/19/2014)... PA (PRWEB) December 19, 2014 ... leading developer and manufacturer of needle-free injection technology, ... agreement with Immunomic Therapeutics, Inc. (“ITI”) for ITI ... device with its LAMP™ vaccine platform. , ... an exclusive Worldwide license to the Biojector®-2000 that ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3
... (Nasdaq: SQNM ) is very pleased to ... 2011;342:c7401) of a groundbreaking international study led by our ... of Hong Kong. Building on early work from the ... of a large-scale clinical study that validates a noninvasive, ...
... MAR, Calif., Jan. 12, 2011 iDiverse today announced that ... Scientific Advisory Board. "We are extremely pleased to ... John Burr, president and CEO of iDiverse. "Dr. Miller has ... commercialization of novel bio-based technologies that have greatly improved the ...
... SeqWright Inc., a world-wide leader in custom genomic ... strides to position itself as the Next-Generation Sequencing ... can be attributed to the company,s ability to ... in key genomics technologies. Building on this success, ...
Cached Biology Technology:Professor Dennis Lo Trisomy 21 Clinical Validation Study Published in British Medical Journal 2Carl A. Miller, PhD, Joins iDiverse's Business and Scientific Advisory Board 2SeqWright Continues Expansion of Next-Generation Sequencing Capabilities 2
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... extinct in Europe 24,000 years ago, but until now the ... mitochondrial DNA sequences from 17 new fossil samples, and compared ... the decline of the cave bear started 50,000 years ago, ... change. "The decline in the genetic diversity of the ...
... University researcher has helped to locate and identify a gene ... terriers. This same gene may be responsible for a similar ... improved screening and diagnosis of the disease in dogs and ... both canines and humans. Dr. Natasha Olby, associate professor ...
... Spanish . A study led ... suggests that a water soluble extract of cinnamon, which ... with diabetes and heart disease. The ... Human Nutrition Research Center (BHNRC) operated by USDA,s ...
Cached Biology News:True causes for extinction of cave bear revealed 2Researchers find gene responsible for neurodegenerative disease in dogs, possibly in humans 2Researchers study cinnamon extracts 2